CARLSBAD, Calif.--(BUSINESS WIRE)--Nov. 9, 2005--Invitrogen Corporation (Nasdaq:IVGN), a leading life sciences company with a broad portfolio of technologies to improve and accelerate biomedical research, drug discovery and commercial bioproduction, today announced the release of its Stealth(TM) RNAi Human Kinase Collection.